OMOP Common Data Model: An Implementation Checklist

Implementing the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) means converting your source health data — electronic health records, claims, registries — into the standardised tables and vocabularies maintained by the Observational Health Data Sciences and Informatics (OHDSI) community, so that analyses written anywhere in the OMOP network run identically on your data. A sound implementation follows six phases: scoping and governance, source data profiling, vocabulary mapping, extract-transform-load (ETL) design and build, data-quality validation, and operationalisation with refresh cycles — with data harmonisation decisions documented at every step.

Why OMOP implementation is on every research roadmap now

OMOP CDM has moved from a research niche to regulatory-grade infrastructure. The European Medicines Agency’s DARWIN EU network — built to supply real-world evidence for regulatory decision-making — standardises its data partners on OMOP, and national programmes across Europe, Asia, and the Americas run OMOP conversions as a condition of joining federated research networks. The current stable version, OMOP CDM v5.4, is documented and maintained openly by OHDSI, and the accompanying tooling — ATHENA for vocabularies, White Rabbit and Rabbit-in-a-Hat for ETL design, ACHILLES and the Data Quality Dashboard for validation — is free and community-tested. The consequence for a data custodian is straightforward: an OMOP-harmonised dataset is a dataset that can join multi-site studies, feasibility networks, and federated analyses without bespoke engineering for each collaboration. Data harmonisation to OMOP is, increasingly, the price of admission to the research economy. For the conceptual grounding, see what data harmonisation is and Lifebit’s detailed OMOP guide.

The Data Harmonisation angle: mapping is a governed decision, not a script

The technical core of an OMOP conversion is deceptively simple — move data into standard tables, code it with standard concepts. The hard part is that every mapping is a semantic judgement: does your source system’s “hypertension, treated” map to the same SNOMED CT concept as a partner hospital’s “HTN on therapy”? Data harmonisation done well treats these judgements as governed artefacts — proposed, reviewed by someone who understands the source system, versioned, and auditable — because a silent mapping error propagates into every downstream study. This is also where artificial intelligence (AI) now earns its place: Lifebit and others apply AI-assisted mapping to propose vocabulary matches and flag inconsistencies at a scale human terminologists cannot, with humans approving the judgements. The aim is not to remove expertise from data harmonisation but to spend it where it matters — on the ambiguous 15%, not the mechanical 85%. In a federated setting, harmonisation happens at each custodian, inside their own environment, so the network gains comparability while data never leaves the source; that pattern is described in Lifebit’s federated Trusted Research Environment.

The implementation checklist, phase by phase

Phase 1 — Scope and governance

Define which source systems, which domains (conditions, drugs, measurements, procedures, visits), and which date ranges are in scope, and who owns each mapping decision. Establish the review board — clinical, terminology, and engineering representation — that signs off on conventions. Decide your refresh cadence up front, because an ETL designed for a one-off conversion is rebuilt, expensively, the first time someone asks for monthly updates.

Phase 2 — Profile the source data

Run White Rabbit (OHDSI’s profiling tool) or equivalent against every source table to measure field completeness, value distributions, and code frequencies. This is where you discover that a third of blood pressures live in free text, or that a legacy system reused a diagnosis field for billing flags. Profiling findings, not assumptions, drive the ETL specification — and they also give you the honest baseline against which mapping-coverage targets in the next phase are set.

Phase 3 — Map vocabularies

Download the standardised vocabularies from OHDSI’s ATHENA service and map local codes to standard concepts — SNOMED CT for conditions, RxNorm for drugs, LOINC for measurements. Use existing community mappings wherever your source vocabularies (ICD-10, local drug catalogues) already have them; reserve manual and AI-assisted effort for local and free-text codes. Record coverage: what percentage of source records map to a standard concept, per domain.

Phase 4 — Design and build the ETL

Specify the transformation with Rabbit-in-a-Hat (or equivalent documentation) before writing code: source field to target field, transformation logic, and the convention decisions — how you assign visit boundaries, how you handle conflicting records, how you populate era tables. Build the ETL as versioned, testable code, and keep the specification synchronised with it; the specification is what a network study’s data-quality reviewer will ask to see. Two conventions deserve particular care because they silently shape every downstream analysis: observation periods, which define when a person is considered “observable” and therefore when an absence of records means absence of disease rather than absence of data; and visit logic, which determines how encounters from different source systems are stitched into the visits that condition and drug records hang from. Write both down as explicit, worked examples in the specification — they are the conventions new team members get wrong first.

Phase 5 — Validate quality

Run ACHILLES for descriptive characterisation and the OHDSI Data Quality Dashboard, which executes thousands of checks organised by the Kahn framework’s categories of conformance, completeness, and plausibility. Set explicit pass thresholds before you run the checks. Then perform clinical face-validity review: do prevalence rates, medication patterns, and demographic distributions look like your population? A conversion can pass structural checks and still be clinically wrong — a drug-exposure table with plausible row counts but a mis-mapped unit field will survive every automated check and quietly corrupt dose-dependent analyses. Face-validity review by a clinician who knows the population is the control that catches this class of error, and it belongs in the release gate, not in an optional appendix.

Phase 6 — Operationalise

Schedule refreshes, monitor quality-check trends across refreshes (a sudden completeness drop is a source-system change announcing itself), version every vocabulary update, and publish a data dictionary and known-limitations document for researchers. An OMOP dataset is a product with users, not a project with an end date — budget for its maintenance the way you would for any production system, including named ownership after the implementation team disbands.

Checklist summary

Real-world reference: harmonisation at network scale

The value of the checklist compounds when the OMOP dataset joins a network. DARWIN EU demonstrates the regulatory version: studies specified once, executed across OMOP-harmonised partners, results combined — the model regulators now expect for real-world evidence. On the research side, national-scale programmes show the federated version: the Canadian Partnership for Tomorrow’s Health (CanPath) makes Canada’s largest population cohort available to researchers through Lifebit’s federated platform, where harmonised data is analysed in place rather than distributed. Genomics England’s federated research infrastructure applies the same principle to genomic and clinical data. In each case, data harmonisation is what makes a federated query meaningful, and federation is what makes harmonisation worth the investment — the two are halves of one architecture, as explained in what federation means.

Common pitfalls

Five failures account for most troubled OMOP projects. Treating the conversion as pure engineering and staffing it without clinical or terminology expertise — the mappings will be syntactically valid and semantically wrong. Skipping profiling and specifying the ETL from the data dictionary the source system claims to have, rather than the data it actually contains. Chasing 100% mapping coverage — the last few percent of legacy codes can consume half the budget for records no study will use; set domain-level coverage targets and document the remainder as known limitations. Running quality checks once, at go-live, instead of on every refresh. And versioning nothing — vocabulary releases, ETL logic, and conventions all change, and a network study reviewer’s first question is “which vocabulary version, which ETL version?”. Every one of these pitfalls is cheaper to prevent in phase 1 than to repair in phase 5.

What to do next

If you are starting an implementation, do three things this month: run White Rabbit against one high-value source system to get real profiling data; read the OMOP CDM v5.4 specification and the Data Quality Dashboard documentation from OHDSI so your team shares the target picture; and draft the governance charter naming who approves mapping conventions. If your organisation intends the OMOP dataset to serve federated research — joining multi-site studies without releasing data — evaluate platforms where harmonisation, quality monitoring, and federated analysis run inside your own boundary, so the dataset becomes network-ready the day it passes validation.

Frequently asked questions

What is the OMOP Common Data Model?

OMOP CDM is an open standard, maintained by the OHDSI community, that defines common table structures and standardised vocabularies for observational health data, so that the same analysis code runs identically across any conforming dataset. The current stable version is v5.4.

How long does an OMOP implementation take?

It depends on source complexity, but typical first conversions of a single EHR or claims source run several months from scoping to validated release. Vocabulary mapping and ETL convention decisions, not coding, usually dominate the timeline — which is why AI-assisted data harmonisation focuses there.

Which tools does OHDSI provide for implementation?

ATHENA distributes the standardised vocabularies; White Rabbit profiles source data; Rabbit-in-a-Hat documents the ETL design; Usagi supports code mapping; and ACHILLES plus the Data Quality Dashboard validate the converted dataset. All are open source.

Do I need to map every source code to a standard concept?

No. Set per-domain coverage targets, prioritise codes by record volume and research relevance, and document unmapped remainders as known limitations. Diminishing returns set in quickly on rare legacy codes.

How is data quality assessed in an OMOP conversion?

Through the OHDSI Data Quality Dashboard, which runs thousands of automated checks structured by the Kahn framework — conformance, completeness, and plausibility — plus clinical face-validity review of prevalence and treatment patterns against the known population.

Can OMOP data stay inside my institution and still support multi-site research?

Yes — that is the federated model. Each custodian harmonises locally; studies travel to the data as code and return aggregate results, so collaboration happens while data never leaves the source. This is the architecture DARWIN EU uses for regulatory evidence and federated TRE platforms use for research networks.